Canopy Growth Corp vs Direxion Daily CSI China Internet Bull 2X Shares — how do they compare? Canopy Growth Corp trades at $1.03 (market cap $421.10M), while Direxion Daily CSI China Internet Bull 2X Shares trades at $23.57. Which is the better fit depends on your goals.
| CGC | CWEB | |
|---|---|---|
Market Cap | $421.10M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $1.92 | $60.13 |
52-Week Low | $0.86 | $17.70 |
Enterprise Value | $378.55M | — |
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $1.02, up 7.13% with a bullish technical signal. The company reported Q1 fiscal 2027 revenue growth of 13% to C$81.2 million and narrowed its EBITDA loss. While revenue trends show stabilization after declining from $520M in 2022 to $269M in 2025, the company continues to post significant net losses with a -222.36% margin. The balance sheet shows improvement with debt-to-asset ratio declining from 53.61% in 2023 to 33.13% in 2025.
CGC presents a high-risk opportunity with potential catalysts from cannabis rescheduling and European expansion. The stock trades below book value (P/B 0.86) but faces substantial execution risks amid persistent losses. Analyst sentiment is mixed with 33% buy ratings, reflecting optimism about restructuring progress versus concerns about profitability timeline.
CWEB is trading at $23.57, down 10.58% over the past 24 hours amid broader market volatility. The technical picture shows mixed signals with a bullish overall rating but bearish moving averages, while fundamental data remains limited pending updated financial disclosures. Recent news suggests potential upside if China-related stocks regain investor favor following semiconductor IPO activity.
The stock faces near-term pressure from the significant daily decline but could benefit from renewed interest in China growth stocks. Key risks include exposure to China market volatility and limited current fundamental visibility. Upside potential exists if sector sentiment improves and company financials demonstrate strength in upcoming earnings reports.
Trailing returns across standard periods
Latest headlines on both assets
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →CWEB is a leveraged ETF that seeks to provide two times (2x) the daily performance of the CSI China Internet Index. It offers magnified exposure to top Chinese internet companies listed on US and Hong Kong exchanges.
Read more on CWEB →